Zurich Insurance (ZURN.S) has agreed to sell its Russian business to members of the local team, it said on Friday, as the Swiss insurer became the latest Western firm to exit Russia.
State conglomerate China Resources is in early-stage talks with Sihuan Pharmaceutical’s (0460.HK) chairman about jointly taking the Hong Kong-listed company private in a deal valuing it at nearly $3 billion, two people with knowledge of the matter said.
China’s policymakers are struggling to find ways to ward off an economic slowdown that threatens job losses in a politically sensitive year, as COVID-19 lockdowns disrupt supply chains and jolt businesses.
Negotiations on new rules for dealing with pandemics will begin at the World Health Organization on Thursday, with a target date of May 2024 for a treaty to be adopted by the U.N. health agency’s 194 member countries.
California health authorities have revealed, the next phase of California’s Covid-19 response.
Britain’s GSK (GSK.L) forecast growth in 2022 after racking up 1.4 billion pounds ($1.9 billion) in COVID-related sales in 2021, beating quarterly forecasts in its first earnings report since rejecting Unilever’s (ULVR.L) bid for its consumer arm.
Japan’s biggest lenders on Wednesday all sounded alarm about the risk the Omicron variant could have on their earnings, reviving concerns that a resurgent pandemic could trigger more bad loans.
Cases of Omicron are spreading like wildfire over the globe.
Some nations are already looking to a fourth vaccine dose to help contend with a huge Omicron-driven spike in COVID-19 cases, but early signs suggest repeat vaccination may be a hard sell as beleaguered populations enter their third pandemic year.
Cities across China are imposing tougher restrictions to try to control new outbreaks of COVID-19, with Tianjin battling the highly contagious Omicron variant which has been detected to have been transmitted locally in two other provinces.
Zurich Insurance (ZURN.S) has agreed to sell its Russian business to members of the local team, it said on Friday, as the Swiss insurer became the latest Western firm to exit Russia.
State conglomerate China Resources is in early-stage talks with Sihuan Pharmaceutical’s (0460.HK) chairman about jointly taking the Hong Kong-listed company private in a deal valuing it at nearly $3 billion, two people with knowledge of the matter said.
China’s policymakers are struggling to find ways to ward off an economic slowdown that threatens job losses in a politically sensitive year, as COVID-19 lockdowns disrupt supply chains and jolt businesses.
Negotiations on new rules for dealing with pandemics will begin at the World Health Organization on Thursday, with a target date of May 2024 for a treaty to be adopted by the U.N. health agency’s 194 member countries.
California health authorities have revealed, the next phase of California’s Covid-19 response.
Britain’s GSK (GSK.L) forecast growth in 2022 after racking up 1.4 billion pounds ($1.9 billion) in COVID-related sales in 2021, beating quarterly forecasts in its first earnings report since rejecting Unilever’s (ULVR.L) bid for its consumer arm.
Japan’s biggest lenders on Wednesday all sounded alarm about the risk the Omicron variant could have on their earnings, reviving concerns that a resurgent pandemic could trigger more bad loans.
Cases of Omicron are spreading like wildfire over the globe.
Some nations are already looking to a fourth vaccine dose to help contend with a huge Omicron-driven spike in COVID-19 cases, but early signs suggest repeat vaccination may be a hard sell as beleaguered populations enter their third pandemic year.
Cities across China are imposing tougher restrictions to try to control new outbreaks of COVID-19, with Tianjin battling the highly contagious Omicron variant which has been detected to have been transmitted locally in two other provinces.
© | All rights reserved.
